Alere Inc  

(Public, NYSE:ALR)   Watch this stock  
Find more results for Alere Toxicology Services, Inc.�
35.56
+0.85 (2.45%)
Apr 16 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 34.88 - 35.72
52 week 24.00 - 39.90
Open 34.94
Vol / Avg. 716,347.00/636,808.00
Mkt cap 2.93B
P/E     -
Div/yield     -
EPS -1.14
Shares 82.51M
Beta 1.92
Inst. own 92%
May 5, 2014
Q1 2014 Alere Inc Earnings Release (Estimated) Add to calendar
Mar 5, 2014
Alere Inc at Raymond James Financial Inc Institutional Investors Conference
Mar 4, 2014
Alere Inc at Goldman Sachs Leveraged Finance Healthcare Conference
Feb 25, 2014
Alere Inc at JPMorgan High Yield & Leveraged Finance Conference
Feb 6, 2014
Q4 2013 Alere Inc Earnings Release
Feb 6, 2014
Q4 2013 Alere Inc Earnings Conference Call
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '13) 2013
Net profit margin -0.97% -2.90%
Operating margin 5.12% 4.45%
EBITD margin - 19.77%
Return on average assets -0.42% -1.24%
Return on average equity -2.46% -6.08%
Employees 17,400 -
CDP Score - -

Address

Suite 200, 51 Sawyer Road
WALTHAM, MA 02453
United States - Map
+1-781-6473900 (Phone)
+1-302-6365454 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Alere Inc. is a provider of point-of-care diagnostics and services. The Company's products and services help healthcare practitioners make treatment decisions and improve outcomes for individuals living with chronic disease. The Company's portfolio also includes a range of health information solutions that access to critical health data, provide clinical decision support, and facilitate performance reporting and analysis. The Company�s segment includes professional diagnostics, health information solutions and consumer diagnostics. The Company distributes its professional diagnostic products to hospitals, reference laboratories, physician offices and other point-of-care settings through an worldwide distribution networks. In February 2013, the Company acquired Epocal, Inc.

Officers and directors

Ron Zwanziger Chairman of the Board, President, Chief Executive Officer
Age: 59
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
David Teitel Chief Financial Officer, Vice President, Treasurer
Age: 49
Bio & Compensation  - Reuters
Michael Lester Cotton President and Chief Executive Officer of Alere Health, LLC
Age: 51
Bio & Compensation  - Reuters
Daniella Cramp Corporate Executive-Global President
Age: 39
Bio & Compensation  - Reuters
Hilde Eylenbosch M.D. President, Europe and Middle East
Age: 49
Bio & Compensation  - Reuters
Sanjay Malkani Corporate Executive-Global President
Age: 43
Bio & Compensation  - Reuters
Avi Pelossof Corporate Executive- Global President
Age: 50
Bio & Compensation  - Reuters
James Post President of Alere North America, Inc.
Age: 50
Bio & Compensation  - Reuters
Kate Torchilin Ph.D. Corporate Executive/Global President and General Manager
Age: 41
Bio & Compensation  - Reuters
Namal Nawana Chief Operating Officer
Age: 42
Bio & Compensation  - Reuters